Sean Martin
About Sean Martin
Sean Martin is the Chief Legal Officer & General Counsel, known for his extensive legal career, including significant roles at Baxter International Inc., Apollo Education Group, Amgen, and Fresenius Medical Care North America.
Sean Martin Chief Legal Officer & General Counsel
Sean Martin serves as the Chief Legal Officer and General Counsel, bringing an extensive background in legal affairs and corporate governance to the role. He has accrued significant experience across various facets of law, including litigation, compliance, and commercial law, backed by a distinguished educational background.
Sean Martin Education and Expertise
Sean Martin graduated summa cum laude with a bachelor's degree in History from the University of Michigan. He later achieved magna cum laude honors at Harvard Law School. This robust academic foundation has propelled a career marked by high-profile legal positions in multiple leading organizations.
Sean Martin Background
At Baxter International Inc., Sean Martin served as General Counsel and Senior Vice President, where he played a pivotal role in overseeing legal, compliance, and government affairs for the company's largest acquisition in history – Hillrom, Inc. His diverse background includes key roles such as Vice President for Commercial Law and Corporate Law at Amgen, and Vice President and Deputy General Counsel for Litigation at Fresenius Medical Care North America. Additionally, he has substantial experience in federal prosecution from his eight years as an Assistant U.S. Attorney in Chicago.
Sean Martin Achievements
Throughout his career, Sean Martin has held several significant positions that underscore his expertise and leadership in the legal field. Notably, as General Counsel, Senior Vice President, and Secretary at Apollo Education Group, and a partner at Foley & Lardner LLP. His tenure at Baxter International Inc. includes overseeing the critical acquisition of Hillrom, Inc., ensuring comprehensive legal and regulatory compliance for this landmark deal.